Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;46(6):735-742.
doi: 10.1055/s-0040-1715450. Epub 2020 Sep 9.

Hemostasis and Liver Regeneration

Affiliations
Review

Hemostasis and Liver Regeneration

Patrick Starlinger et al. Semin Thromb Hemost. 2020 Sep.

Abstract

The liver is unique in its remarkable regenerative capacity, which enables the use of liver resection as a treatment for specific liver diseases, including removal of neoplastic liver disease. After resection, the remaining liver tissue (i.e, liver remnant) regenerates to maintain normal hepatic function. In experimental settings as well as patients, removal of up to two-thirds of the liver mass stimulates a rapid and highly coordinated process resulting in the regeneration of the remaining liver. Mechanisms controlling the initiation and termination of regeneration continue to be discovered, and many of the fundamental signaling pathways controlling the proliferation of liver parenchymal cells (i.e., hepatocytes) have been uncovered. Interestingly, while hemostatic complications (i.e., bleeding and thrombosis) are primarily thought of as a complication of surgery itself, strong evidence suggests that components of the hemostatic system are, in fact, powerful drivers of liver regeneration. This review focuses on the clinical and translational evidence supporting a link between the hemostatic system and liver regeneration, and the mechanisms whereby the hemostatic system directs liver regeneration discovered using experimental settings.

PubMed Disclaimer

Conflict of interest statement

Dr. Groeneveld reports grants from the European Hematology Association during the conduct of the study. Dr. Luyendyk reports grants from the National Institutes of Health during the conduct of the study.

Figures

Figure 1:
Figure 1:
Mechanisms linking hemostatic factors to liver regeneration: Platelets rapidly accumulate in the liver remnant after partial hepatectomy. Accumulation of platelets in the liver appears to depend on multiple factors including von Willebrand factor (VWF), and on fibrin deposits formed as a result of intrahepatic coagulation. Experimental evidence suggests that platelets contribute to liver regeneration through multiple mechanisms including 1) degranulation and release of serotonin and other growth factors, 2) transfer of RNA by direct interactions with hepatocytes and 3) potentially through cell-cell interactions with leukocytes or other non-parenchymal cells. Among the gaps in knowledge include the source of VWF responsible for driving platelet accumulation (plasma, endothelial cells or platelets themselves), and whether fibrin drives regeneration through mechanisms independent of its role in platelet accumulation. TF = Tissue factor VWF = von Willebrand factor EC = Endothelial Cell HPC = Hepatocyte

References

    1. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M: Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. British journal of cancer 2006, 94:982–99. - PMC - PubMed
    1. Van Cutsem E, Nordlinger B, Adam R, Kohne CH, Pozzo C, Poston G, Ychou M, Rougier P: Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. European journal of cancer (Oxford, England : 1990) 2006, 42:2212–21. - PubMed
    1. Bramhall SR, Gur U, Coldham C, Gunson BK, Mayer AD, McMaster P, Candinas D, Buckels JA, Mirza DF: Liver resection for colorectal metastases. Annals of the Royal College of Surgeons of England 2003, 85:334–9. - PMC - PubMed
    1. Adam R, de Haas RJ, Wicherts DA, Aloia TA, Delvart V, Azoulay D, Bismuth H, Castaing D: Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008, 26:3672–80. - PubMed
    1. Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM, McWilliams RR: Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009, 27:3677–83. - PMC - PubMed